Sanofi-Aventis Deutschland GmbH

Frankfurt am Main, Germany

Leading scientists

Oliver Plettenburg
Pablo Juretschke


Sanofi-Aventis Deutschland GmbH is an internationally recognised pharmaceutical company and centre of expertise for drug development. In 2010, a Diabetes Division has been created with Frankfurt as the headquarter, also reflecting the long-standing track record of the Frankfurt site in diabetes R&D. Within pharma R&D projects, animal disease models, biomarkers and small animal imaging for non-invasive longitudinal monitoring of physiology and therapy success are routinely applied. There is access to state-of-the-art small animal imaging facilities (small animal 4.7 and 7 Tesla MRI scanners, optical imaging fluorescence scanner). In addition, fully equipped labs for animal pharmacology, biomarker measurements, medicinal chemistry, synthesis and analysis of (bio-)conjugates exist.